CONMED Corp — Director's Dealing 2018

Apr 30, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-04-27

Reporting Person: Folkert Nathan (VP GM Orthopedics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-27	Common Stock	M	296	$41.93	Acquired	1264	Direct
2018-04-27	Common Stock	M	4113	$39.87	Acquired	5377	Direct
2018-04-27	Common Stock	S	4409	$64.98	Disposed	968	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-27	Options To Purchase Common Stock	$41.93	M	296	Disposed	2027-03-01	Common Stock (296)	Direct
2018-04-27	Options To Purchase Common Stock	$39.87	M	4113	Disposed	2026-03-01	Common Stock (4113)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.92 to $65.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period